Brief: SynAct Pharma Q4 Pretax Loss Narrows To SEK 6.9 Million

SynAct Pharma AB

11/02/2020 08:05

Feb 11 (Reuters) - SynAct Pharma AB  SYNACT.TE :
    * Q4 PRETAX LOSS SEK 6.9 MILLION VERSUS LOSS SEK 7.5 MILLION
YEAR
AGO
    * PROPOSES NO DIVIDEND FOR 2019

Source text for Eikon:  ID:nWkr536v3f 
Further company coverage:  SYNACT.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))